Geron Corporation (GERN) is a biotechnology company listed on US.
Latest reported GERN revenue for 2026-06-30 was $109.3M. Net income was -$20.3M. GERN currently screens at market cap $878.9M.
Use this GERN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the GERN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the GERN SEC filings page. Lician reads the product cache first so this HTML stays unique to Geron Corporation even when a live quote feed is slow.
Latest cached year on this hub. Full GERN income, balance, and cash tables.